Health Condition 1: C530- Malignant neoplasm of endocervix
Conditions
Interventions
Intervention1: Dexmedetomidine and ketamine: 2ml(5mcg/cc dexmedetomidine + 2.5 mg/cc ketamine) administered 2-3 times intravascularly,during the period from initiation of procedure till full recovery.
Sponsors
CMCH BHOPAL
Eligibility
Inclusion criteria
Inclusion criteria: All patients belonging to ASA grade 1 and 2 undergoing their first cycle of ICRT applicator insertion at CMCH Bhopal
Exclusion criteria
Exclusion criteria: ASA grade 3 and 4 Patients with cardiac diseases(ejection fraction Patients with any psychological disorder Patient with renal disorders
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Assess the quality of sedation recorded every 5 min and recovery timeTimepoint: every minute till 3 min follwed by 5 min intervals till recovery | — |
Secondary
| Measure | Time frame |
|---|---|
| Haemodynamic and respiratory variables total ketamine consumption total opiod consumption incidence of adverse eventsTimepoint: every minute till 3 min follwed by 5 min intervals till recovery for Haemodynamic and respiratory variables After recovery for total ketamine consumption total opiod consumption incidence of adverse events | — |
Countries
India
Contacts
Public ContactSOHINI DATTA
CHIRAYU MEDICAL COLLEGE AND HOSPITAL
Outcome results
None listed